Howard M. Sandler, MD, on Prostate Cancer: Results of NRG Oncology/RTOG 9601
2015 ASTRO Annual MeetingHoward M. Sandler, MD, of Cedars-Sinai Medical Center, discusses how adding 24 months of daily antiandrogen therapy during and after radiotherapy was shown to significantly improve long-term overall survival following prostate cancer recurrence after a radical prostatectomy (Abstract LBA5).